Condition: Patient Satisfaction · Vascular Access Complication · Sponsor: Minneapolis Heart Institute Foundation
This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial infarction undergoing cardiac catheterization. Subjects will be randomized 1:1 into 2 treatment groups: radial access and state-of-the-art femoral access. Randomization will be performed in blocks of 50 per site. Similarly, a second sub-randomization will be performed in the femoral access group into use of 18 vs 21 gauge needles, also in a 1:1 fashion.
This description comes directly from the study's public registry record.
Bavana Rangan, BDS, MPH, CCRP · 612-863-3852 · bavana.rangan@allina.com
Olga Mastrodemos · olga.mastrodemos@allina.com
Always discuss trial participation with your own doctor first.
| San Francisco VA Medical Center | San Francisco, California, United States | Recruiting |
| Mayo Clinic Florida | Jacksonville, Florida, United States | Recruiting |
| Joseph Maxwell Cleland Atlanta VA Medical Center | Decatur, Georgia, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Not Yet Recruiting |
| Minneapolis Heart Institute Foundation | Minneapolis, Minnesota, United States | Recruiting |
| Oklahoma Heart Hospital | Oklahoma City, Oklahoma, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04077762